Works by HU Yong-jie


Results: 25
    1
    2
    3
    4
    5

    Disorder in M<sub>n+1</sub>AX<sub>n</sub> phases at the atomic scale.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08588-1
    By:
    • Wang, Chenxu;
    • Yang, Tengfei;
    • Tracy, Cameron L.;
    • Lu, Chenyang;
    • Zhang, Hui;
    • Hu, Yong-Jie;
    • Wang, Lumin;
    • Qi, Liang;
    • Gu, Lin;
    • Huang, Qing;
    • Zhang, Jie;
    • Wang, Jingyang;
    • Xue, Jianming;
    • Ewing, Rodney C.;
    • Wang, Yugang
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome.

    Published in:
    Cancer Communications, 2021, v. 41, n. 3, p. 279, doi. 10.1002/cac2.12136
    By:
    • Ju, Wu‐tong;
    • Liu, Ying;
    • Wang, Li‐zhen;
    • Li, Jiang;
    • Ren, Guo‐xing;
    • Sun, Jian;
    • Tu, Wen‐yong;
    • Hu, Yong‐jie;
    • Ji, Tong;
    • Yang, Wen‐jun;
    • Li, Jun;
    • He, Yue;
    • Wang, Yan‐an;
    • Zhang, Chen‐ping;
    • Zhong, Lai‐ping;
    • Zhang, Zhi‐yuan
    Publication type:
    Article
    20
    21
    22
    23
    24
    25